Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $79.16 ($342K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Scheduled sale ($342k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.16 | 3,026 | $240K | 70.1% |
| 2 | $79.97 | 1,276 | $102K | 29.9% |
| Total | $79.40 avg | 4,302 | $342K | 100% |
| Filing → |
| PVLA | SELL | 2026-07-17 | $642K | — | Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |